Cite
HARVARD Citation
Johnson, K. et al. (2016). Tissue Factor Pathway Inhibitor, Activated Protein C Resistance, and Risk of Coronary Heart Disease Due To Combined Estrogen Plus Progestin Therapy. Arteriosclerosis, thrombosis, and vascular biology. 36 (2), p. . [Online].